News

In-Depth Insights into D-Wave Quantum's Trading Activities

In-Depth Insights into D-Wave Quantum's Trading Activities

Analyzing the Trading Trends of D-Wave Quantum

Recent market observations indicate that investors are bullish on D-Wave Quantum, as their trading movements reflect a clear sentiment toward growth.

Options Trading Performance Overview

In our analysis of D-Wave Quantum (NYSE: QBTS), we identify that there were 68 trades recorded. Notably, 52% of these trades were initiated with bullish expectations, whereas 41% leaned towards a bearish perspective. The divide showcases an engaged dynamics among traders, displaying varied confidence levels regarding the stock's future performance.

Trade Details and Financial Insights

The breakdown of these trades reveals significant financial commitments: 15 were puts, totaling $825,163, while 53 were calls, accounting for $5,779,264. These figures mirror a strategic positioning by various investors in D-Wave's financial landscape.

Expected Market Movements

Having assessed trading volumes alongside Open Interest, it emerges that substantial market players are concentrating their interests within a price range of $7.0 to $65.0 over the past three months. This observation suggests that the market is poised for transformative shifts, potentially influenced by the underlying operations of D-Wave Quantum.

Current Volume and Open Interest Insights

In terms of liquidity, today’s mean open interest for D-Wave Quantum options trades stands at approximately 1,804.24, coupled with a notable total trade volume hitting 41,205. These figures indicate a vibrant trading environment bolstered by investor interest.

30-Day Options Volume Overview

Recent data allows us to investigate trends in call and put options for D-Wave Quantum, notably highlighting movement within the strike price range of $7.0 to $65.0 over the last month. The increasing trade velocities in this range imply a growing activity that may capture future investor attention.

Top Options Transactions

Below are some significant options trades identified for D-Wave Quantum:

Noteworthy Trades

1. A bullish call option trade for QBTS at a $9.5 ask with a total trade price reaching $760K.

2. Conversely, a bearish sweep was recorded at an $11.35 ask, indicating a strategic divergence in sentiment among traders.

3. Another bullish stance was evident in a trade at $10.5, showcasing how various options align with market expectations.

About D-Wave Quantum

D-Wave Quantum Inc is pioneering the development and commercial delivery of quantum computing systems and services, making strides as the sole provider of both annealing and gate-model quantum computers. These pioneering technologies cater to a multitude of applications, including logistics and drug discovery, capturing substantial interest across diverse sectors.

Positioning in the Current Market

  • D-Wave Quantum is currently trading with a volume of 30,489,243 and has reported a decrease of -10.28%, settling at $40.17.
  • Relevant RSI readings suggest the stock is traversing a neutral zone between overbought and oversold conditions.
  • Experts anticipate an upcoming earnings release in the next month, further contributing to ongoing market dialogues.

Expert Opinions on D-Wave Quantum

Amid prevalent market analysis, a recent review from an industry expert has suggested a target price of $33. This outlook aligns with a general sentiment towards potential growth in this innovative sector.

Profiting from Strategic Options Insights

Traders are empowered by knowledge of options trading, emphasizing the importance of ongoing education and strategic adjustments. The approach to market movements continues to evolve, reinforcing the significance of real-time data and analytical insights concerning D-Wave Quantum.

Frequently Asked Questions

What is the current sentiment toward D-Wave Quantum?

The sentiment appears bullish with 52% of trades indicating optimism regarding the company's future performance.

How many trades were reported for D-Wave Quantum?

There were a total of 68 trades reported, showcasing significant investor activities.

What is the expected price range for D-Wave Quantum?

Market movers are focusing on a price band between $7.0 and $65.0 for D-Wave Quantum based on recent trading activity.

What is D-Wave Quantum's market position currently?

D-Wave Quantum is trading at $40.17, reflecting a decrease of -10.28% over recent engagements.

What do analysts suggest about D-Wave Quantum?

Analysts have projected an average target price of $33 for D-Wave Quantum reflecting potential growth in the coming period.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WIN Expands Global Family Support to 124 Countries

Updated Category News Views 55

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 31

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 202

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 71

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
New Leadership at Reactive Tech: Claudio Facchin Steps In

Updated Category News Views 154

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Continue Reading
Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 106

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading
Target Hospitality's Growth and Earnings Analysis Q3 2026

Updated Category News Views 64

Strategic Transformation: A Mixed Bag of Results In the raucous world of high-stakes business, folks, Target Hospitality Corp. (NASDAQ: TH) is making quite the noise. For Q3 2026, they trumpeted a juicy $129.1 million in revenue, which is a solid notch up by 30% from a year before. Yet, like a seasoned trader facing a knife-edge call, they're handling a bittersweet...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 47

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 132

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 55

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Qatar Airways Reveals New Lounge and Terminal at JFK Airport

Updated Category News Views 254

Qatar Airways Expands Presence at JFK Airport Qatar Airways is set to enhance its operations at John F. Kennedy International Airport by moving to the New Terminal One, which promises a first-of-its-kind experience for travelers in the United States. This airline, renowned for its exceptional service, is preparing to introduce a dedicated lounge in 2026, significantly...

Continue Reading
Venture Global Faces Class Action Amid Legal Challenges

Updated Category News Views 227

Venture Global Faces Legal Action Venture Global, Inc. has recently been embroiled in a securities class action lawsuit filed in the Southern District of New York. The lawsuit pertains to all individuals or entities who acquired Venture's securities during its initial public offering around January 2025, seeking to recover damages under federal securities laws. Claims of...

Continue Reading
Join Aclaris Therapeutics' R&D Day on Immuno-Inflammatory Gaps

Updated Category News Views 151

Aclaris Therapeutics R&D Day Focused on Patient Needs Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a biopharmaceutical organization based in Pennsylvania, is set to host its highly anticipated R&D Day. This event is dedicated to exploring the evolving landscape of immuno-inflammatory diseases and the innovative solutions that the company is developing. The R&D Day will take...

Continue Reading
Cloudelligent Achieves Sixth Ranking in Global MSP List

Updated Category News Views 137

Cloudelligent Celebrates Top Ranking in MSP 501 Cloudelligent, a prominent Managed Cloud Services provider, has reached an impressive milestone by being recognized as the sixth-ranked company on Channel Futures' prestigious MSP 501 list for the year. This distinction is not merely a testament to their robust performance; it underscores their relentless commitment to...

Continue Reading
Lithia Motors Sees Earnings Growth, Yet Shares Decline

Updated Category News Views 116

Lithia Motors Reports Strong Financial Performance Why are Lithia Motors, Inc.‘s shares slipping despite a substantial earnings beat and impressive profitability growth? As investors grapple with mixed signals from the company’s latest financial performance, the story behind the numbers holds the key to understanding market reactions. Lithia Motors shares are trading...

Continue Reading